Tailwind Biotech ApS — Credit Rating and Financial Key Figures
CVR number: 43630938
Ørestads Boulevard 55 A, 2300 København S
contact@tailwindbiotech.com
www.tailwindbiotech.com
Income statement (kDKK)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | 321.53 | 852.65 |
Employee benefit expenses | - 330.20 | - 897.63 |
EBIT | -8.68 | -44.98 |
Other financial expenses | -2.07 | |
Pre-tax profit | -8.68 | -47.04 |
Income taxes | 4.56 | 20.38 |
Net earnings | -4.12 | -26.66 |
Assets (kDKK)
2023 | 2024 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Investments total | ||
Long term receivables total | ||
Inventories total | ||
Current other receivables | 11.09 | |
Current deferred tax assets | 4.56 | 20.38 |
Short term receivables total | 15.65 | 20.38 |
Cash and bank deposits | 52.57 | 28.13 |
Cash and cash equivalents | 52.57 | 28.13 |
Balance sheet total (assets) | 68.22 | 48.52 |
Equity and liabilities (kDKK)
2023 | 2024 | |
---|---|---|
Share capital | 40.00 | 40.00 |
Retained earnings | -4.12 | |
Profit of the financial year | -4.12 | -26.66 |
Shareholders equity total | 35.88 | 9.22 |
Non-current liabilities total | ||
Current trade creditors | 11.00 | 11.00 |
Other non-interest bearing current liabilities | 21.34 | 28.30 |
Current liabilities total | 32.34 | 39.29 |
Balance sheet total (liabilities) | 68.22 | 48.52 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.